Publicaciones referentes en anemia renal
2007 Feb
Levin A.
Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR.
Nephrol Dial Transplant. 2007 Feb;22(2):309-12.
2007 Feb
Bunn HF.
2006 Nov
Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators.
Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
N Engl J Med. 2006 Nov 16;355(20):2071-84. Comment in: N Engl J Med. 2006 Nov 16;355(20):2144-6.
2006 Nov
Remuzzi G, Ingelfinger JR.
2006 Nov
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators.
Correction of anemia with epoetin alfa in chronic kidney disease.
N Engl J Med. 2006 Nov 16;355(20):2085-98. Comment in: N Engl J Med. 2006 Nov 16;355(20):2144-6.
2006 Sep
Macdougall IC, Eckardt KU
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia.
Lancet. 2006 Sep 9;368(9539):947-53.
2005 Oct
Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik JM, Ferrucci L.
Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.
Arch Intern Med. 2005 Oct 24;165(19):2222-7.
2005 May
Chatterjee PK.
Pleiotropic renal actions of erythropoietin.
Lancet. 2005 May 28-Jun 3;365(9474):1890-2.
2005 Jan
Maiese K, Li F, Chong ZZ.
[No date]
National Kidney Foundation KDOQI
V. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients.
1998 Aug
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA.
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
Engl J Med. 1998 Aug 27;339(9):584-90.
1993 Jan
Rao DS, Shih MS, Mohini R.
Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
N Engl J Med. 1993 Jan 21;328(3):171-5
1991 Mar
Nissenson AR, Nimer SD, Wolcott DL.
Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects.
Ann Intern Med. 1991 Mar 1;114(5):402-16.
1991 Feb
Taylor JE, Henderson IS, Mactier RA, Stewart WK.
1990 Mar
[No authors listed] Canadian Erythropoietin Study Group.
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis.
BMJ. 1990 Mar 3;300(6724):573-8.
1987 Jan
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
N Engl J Med. 1987 Jan 8;316(2):73-8.
Sea el primero en estar informado
Suscríbase a las publicaciones más recientes, a las noticias y a los anuncios de diversos eventos
